PPARA and intrahepatic cholestasis: A combination of PPARα agonist fenofibrate and UDCA could decrease serum AST, ALT, ALP, γ-glutamyl transpeptidase, and TG in PBC (classic intrahepatic cholestasis) patients, who are not responsive to UDCA alone (Ghonem and Boyer, 2013).